Indian Graves’ disease market is growing at a CAGR of around 6.7% during the forecast period. India is continuously working towards positioning itself as a major region in the technological development and industrialization. There are various large companies in the country which are increasingly focusing on the development of advanced healthcare solutions for humans. The emerging economy such as India has a wide scope in the field of diabetes treatment due to improving government policies, economic reforms, medical tourism, rising diabetes patients, and growth of the diagnostic sector.
To Request a Sample of our Report on Indian Graves’ disease Market: https://www.omrglobal.com/request-sample/indian-graves-disease-market
Further, Thyroid disorders are considered as one of the most popular diseases that is producing significant burden on the healthcare sector in India and affects the Indian graves’ disease market. According to the Public Health Foundation of India, there is over one-third of the population of the country that suffers from thyroid disorders, accounting to around 32% of Indians suffering from various forms of thyroid disorders. In hyperthyroidism, there are several patients suffering from Grave’s disease and toxic multinodular goiter in India, which are opting surgical management for permanent remission of the disease. Hence, such leads to the demand for the treatment, and in turn fuels the Indian Graves’ disease market growth.
Furthermore, increasing medical tourism is also expected to accelerate the Indian Grave’s disease market. According to International Brand Equity Foundation (IBEF), Indian healthcare market can increase three-fold to nearly $133.4 billion in 2022. The country is experiencing growth of around 22-25% in medical tourism every year. The healthcare industry was expected to double its size from approximately $3 billion in 2017 to nearly $6 billion in 2018. In addition, medical tourist arrivals in India rose to around 1.1 million in January 2018 from approximately 0.9 million in January 2017. This growth in medical tourism is resulting due to cost-effective medical service and improved healthcare infrastructure in India, which further influences the Indian Graves’ disease market growth.
(Get 15% Discount on Buying this Report)
A full Report of Indian Graves’ disease Market is Available @ https://www.omrglobal.com/industry-reports/indian-graves-disease-market
Indian Graves’ Disease Market Segmentation
By Diagnosis
- Ultrasound
- Imaging Tests
- Radioactive Iodine Uptake
- Blood Sample
By Treatment
- Anti- Thyroid Medication
- Radioactive Iodine Therapy
- Surgery
Company Profiles
- Abbott Laboratories Inc.
- Allergan PLC
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Macleods Pharmaceuticals Ltd.
- Merck & Co. Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
